Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
ENVB | US
-0.08
-3.77%
Healthcare
Biotechnology
30/06/2024
10/04/2026
1.96
2.02
2.05
1.96
Enveric Biosciences Inc. a biotechnology company engages in the development of small-molecule therapeutics for the treatment of anxiety depression and addiction disorders. Its lead program is EB-373 an active metabolite of psilocybin which is in Phase 1 clinical trials for the treatment of anxiety disorders; EVM-301 for treating mental health; and EV104 CBD + Celecoxib conjugate for treating osteoarthritis. The company also developing cannabinoid-infused topical product for the treatment of radiodermatitis; and cannabinoid and COX-2 inhibitor conjugation that is in pre-clinical stage for the treatment of OA/acute pain. Enveric Biosciences Inc. is headquartered in Naples Florida.
View LessLow Market Beta (-0.4 to 0.8)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bearish: Increased Volatility (6-month > 1-month volatility)
10 days
85.6%1 month
65.9%3 months
89.3%6 months
171.1%-
23.09
0.73
-
-
0.29
1.76
-
-9.87M
17.51M
17.51M
-
-
-
-7.30
-206.10
1.86
2.25
Short-term: Bullish (SMA10D > SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.45
Range1M
0.45
Range3M
2.92
Rel. volume
0.66
Price X volume
39.18K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| PLUR | PLUR | Biotechnology | 3.32 | 18.16M | -2.06% | n/a | 30845.83% |
| DOMH | DOMH | Biotechnology | 2.88 | 18.08M | 0.00% | n/a | 7.66% |
| Edesa Biotech Inc | EDSA | Biotechnology | 5.52 | 17.93M | -6.76% | n/a | 1.35% |
| Can-Fite BioPharma Ltd | CANF | Biotechnology | 2.92 | 17.80M | -0.34% | n/a | 0.00% |
| Cingulate Inc. Common Stock | CING | Biotechnology | 5.76 | 17.53M | -3.36% | n/a | 10.72% |
| Inhibikase Therapeutics Inc. | IKT | Biotechnology | 1.7 | 16.96M | 0.59% | n/a | 3.49% |
| Longeveron Inc. Class A Common Stock | LGVN | Biotechnology | 1.16 | 16.66M | 4.50% | n/a | 11.72% |
| HCW Biologics Inc. Common Stock | HCWB | Biotechnology | 0.3645 | 15.90M | 8.06% | n/a | -159.13% |
| Aytu BioScience Inc | AYTU | Biotechnology | 2.55 | 15.68M | -0.39% | n/a | 54.59% |
| DarT Bioscience Inc | DARE | Biotechnology | 1.83 | 15.64M | -1.08% | 0.12 | 218.34% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Beasley Broadcast Group Inc | BBGI | Broadcasting - Radio | 11.76 | 17.91M | 6.72% | n/a | 204.46% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.08 | 15.78M | -6.90% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.601 | 11.61M | -7.68% | n/a | 58.43% |
| EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.34 | 3.42M | 3.08% | n/a | 17.32% |
| Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.2536 | 2.41M | -15.10% | n/a | 19.98% |
| Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 2.09 | 1.15M | 7.18% | n/a | 0.00% |
| Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.006 | 553.29K | n/a | -37.05% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 0.29 | - | Cheaper |
| Ent. to Revenue | 1.76 | - | Cheaper |
| PE Ratio | - | 41.03 | - |
| Price to Book | 0.73 | 15.55 | Cheaper |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 89.30 | - | Riskier |
| Debt to Equity | - | -1.23 | - |
| Debt to Assets | - | 0.25 | - |
| Market Cap | 17.51M | - | Emerging |